No abstract available
Keywords:
Atherosclerotic cardiovascular disease; Clinical trial; Gene editing; Lipid-lowering therapy; PCSK9 inhibitor.
MeSH terms
-
Anticholesteremic Agents*
-
Cardiovascular Diseases*
-
Gene Editing
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
-
Lipids
-
PCSK9 Inhibitors
-
Proprotein Convertase 9 / genetics
Substances
-
Anticholesteremic Agents
-
PCSK9 Inhibitors
-
Lipids
-
Proprotein Convertase 9
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors